Oncology Drugs Market
Pharmaceuticals

Global Oncology Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends

The Global Oncology Drugs Market Report by The Business Research Company covers oncology drugs market drivers and restraints, oncology drugs market size, major players, and the impact of COVID-19 on the oncology drugs market.

The oncology drugs market consists of sales of oncology drugs and related services by entities (organizations, sole traders and partnerships) that produce oncology drugs to diagnose and treat all types of cancers. This industry includes establishments that produce drugs used in chemotherapy, surgery and radio therapies for treating pancreatic cancer, breast cancer, ovarian cancer, gastric cancer, kidney cancer, brain tumor, and other cancer types.

The global oncology drugs market reached a value of nearly $160.45 billion in 2020, having increased at a compound annual growth rate (CAGR) of 6.8% since 2015. The market is expected to grow from $160.45 billion in 2020 to $243.81 billion in 2025 at a rate of 8.7%. The growth is mainly due to rise in incidence of various cancer conditions, increase in popularity of advance therapies (biological and targeted drug therapies), and surge in geriatric population worldwide. The oncology drugs market is expected to grow slightly from $160.45 billion in 2020 to $167.52 billion in 2021 at a CAGR of 4%. The market is expected to stabilize and reach $243.81 billion in 2025 and $358.45 billion in 2030.

Increasing aging population is expected to increase the prevalence of cancer cases contributing to the growth of the oncology drugs market. The elderly population is increasing rapidly across the world and it is expected to continue over the forecast period. The expected increase in the aging population suffering from cancer is expected to drive the oncology drugs market.

Request A Sample For The Global Oncology Drugs Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3440&type=smp

Some oncology drugs market trends include increasingly investing in technologies such as artificial intelligence (AI) to save time and reduce research and development costs. Moreover, the development of clustered regularly interspaced short palindromic repeats associated protein 9 (CRISPR-Cas9) technology has shown potential to treat cancer. CRISPR technology can be used to discover the non-coding cancer genome. The technology has entered into clinical trials in the oncology space focused on reprogramming immune cells to the target and destroys tumor cells.

Global oncology drugs market segments include:

1) By Type: Lung Cancer Drugs, Pancreatic Cancer Drugs, Breast Cancer Drugs, Prostate Cancer Drugs, Ovarian Cancer Drugs, Colorectal Cancer Drugs, Gastric Cancer Drugs, Kidney Cancer Drugs, Brain Tumor Drugs, Thyroid Cancer Drugs, Skin Cancer Drugs, Bladder Cancer Drugs, Cervical Cancer Drugs, Blood Cancer Drugs, Others

2) By Drug Class: Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others

4) By Route Of Administration: Oral, Parenteral, Others

5) By Drug Classification: Branded Drugs, Generic Drugs

6) By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

 

Read More On The Oncology Drugs Opportunities And Strategies: Forecast To 2030:

https://www.thebusinessresearchcompany.com/report/oncology-drugs-market

 

The Oncology Drugs Opportunities And Strategies: Forecast To 2030 is one of a series of new reports from The Business Research Company that provides oncology drugs market overviews, analyzes and forecasts market size, share, oncology drugs market players, oncology drugs market segments and geographies, market’s leading competitors’ revenues, profiles and market shares.

The oncology drugs identify top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Where To Learn More:

Read Oncology Drugs Opportunities And Strategies: Forecast To 2030 from The Business Research Company for information on the following:

Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries

Market Players Covered: F. Hoffmann-La Roche Ltd, Novartis AG, Takeda Pharmaceuticals, Gilead Sciences Inc., Bristol-Myers Squibb (Celgene)

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

Other Information And Analyses: SWOT analysis, customer information, market product/service analysis – product examples, trends and opportunities, drivers and restraints, key mergers and acquisitions, suggested trend based strategies, impact of COVID-19 on the market, future outlook and potential analysis, key metrics covered: number of enterprises, number of employees, global market in 2021 – countries offering most new opportunities, conclusions and recommendations by expert analysts.

Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes.

Strategies For Participants In The Oncology Drugs Industry: The report explains a number of strategies for companies in the market, based on industry trends and company analysis.

Opportunities For Companies In The Oncology Drugs Sector: The report reveals where the global industry will put on most $ sales up to 2023.

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at www.thebusinessresearchcompany.com

Here is a list of reports from The Business Research Company similar to the Oncology Drugs Opportunities And Strategies: Forecast To 2030:

Oncology Biosimilars Global Market Report 2021

Oncology Molecular Diagnostics Global Market Report 2021

Pharmaceutical Drugs Market

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company

Follow us on Twitter: https://twitter.com/tbrc_info

Check out our Blog: https://blog.tbrc.info/

Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Leave a Reply

Your email address will not be published. Required fields are marked *